F. Haguinet

发表

Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK

Robert J. Taylor, J. Logie, D. Fleming, 2016, BMJ Open.

Model estimates of the burden of outpatient visits attributable to influenza in the United States

Robert J. Taylor, G. Chowell, R. Lustig, 2016, BMC Infectious Diseases.

Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study

I. Nazareth, V. Bauchau, D. Rosillon, 2013, BMJ Open.

Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014.

S. Trottier, M. Loeb, B. Light, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Clinical Features of Influenza and Acute Respiratory Illness in Older Adults at Least 50 Years of Age in an Outpatient Setting in the Republic of Korea: a Prospective, Observational, Cohort Study

F. Haguinet, G. Matias, R. Ray, 2017, Journal of Korean medical science.

The epidemiology of herpes zoster and its complications in Medicare cancer patients

A. LaCasce, F. Haguinet, M. Duh, 2015, BMC Infectious Diseases.

Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series

J. Logie, V. Shinde, D. Rosillon, 2016, BMJ Open.

Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study

S. de Lusignan, R. Byford, F. Ferreira, 2019, JMIR public health and surveillance.

Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study (Preprint)

S. de Lusignan, R. Byford, F. Ferreira, 2018 .

Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada

S. Trottier, M. Loeb, A. Chit, 2017, BMC Infectious Diseases.

Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000–2012

F. Haguinet, Emad Yanni, V. Bianco, 2018, BMJ Open.

Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view.

V. Bauchau, D. Rosillon, L. Baril, 2017, Vaccine.

Dengue Infection in Children in Fortaleza, Brazil: A 3-Year School-Based Prospective Cohort Study

F. Haguinet, A. Guignard, A. Duarte, 2020, The American journal of tropical medicine and hygiene.

Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).

S. Trottier, M. Loeb, A. Chit, 2018, Vaccine.

Interim estimates of 2014/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalisation from the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network, January 2015.

M. Loeb, V. Shinde, M. Andrew, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness (VE) to Prevent Influenza-Related Hospitalizations over Four Influenza Seasons in Canada.

S. Trottier, M. Loeb, V. Shinde, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People

S. Trottier, M. Loeb, A. Chit, 2017, The Journal of infectious diseases.

Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception

F. Haguinet, Frédérique Delannois, T. Singh, 2022, Drug Safety.

Estimates of hospitalization attributable to influenza and RSV in the US during 1997–2009, by age and risk status

Robert J. Taylor, C. Schuck-Paim, V. Shinde, 2017, BMC Public Health.

Impact of Frailty on Influenza Vaccine Effectiveness and Clinical Outcomes: Experience from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network 2011/12 Season

S. Trottier, M. Loeb, B. Light, 2016 .

Estimates of mortality attributable to influenza and RSV in the United States during 1997–2009 by influenza type or subtype, age, cause of death, and risk status

C. Schuck-Paim, V. Shinde, R. Lustig, 2014, Influenza and other respiratory viruses.

Influenza Vaccine Effectiveness in the Prevention of Influenza-Related Hospitalization in Canadian Adults Over the 2011/12 Through 2013/14 Season: A Pooled Analysis From the Serious Outcomes Surveillance (SOS) Network of the Canadian Influenza Research Network (CIRN)

S. Trottier, M. Loeb, B. Light, 2016 .

Modelling estimates of age-specific influenza-related hospitalisation and mortality in the United Kingdom

Robert J. Taylor, D. Fleming, C. Schuck-Paim, 2016, BMC Public Health.

Influenza-attributable burden in United Kingdom primary care

J. Logie, D. Fleming, C. Schuck-Paim, 2015, Epidemiology and Infection.

Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom

Robert J. Taylor, J. Logie, D. Fleming, 2015, BMC Infectious Diseases.

Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series.

J. Logie, V. Shinde, D. Rosillon, 2016, Vaccine.

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD

S. Trottier, M. Loeb, A. Chit, 2019, Chest.

ADVANCE system testing: Estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data.

S. de Lusignan, M. Sturkenboom, M. D. de Ridder, 2020, Vaccine.

Prevalence and Persistence of Maternal Dengue Neutralizing Antibodies in Infants From Central and Southern Thailand: A Retrospective Cohort Study

F. Haguinet, A. Guignard, Phirangkul Kerdpanich, 2019, Asia-Pacific journal of public health.

ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination.

M. Sturkenboom, Lara Tramontan, K. Bollaerts, 2019, Vaccine.

Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology

Harry Seifert, F. Haguinet, F. Tavares-da-Silva, 2020, Drug Safety.

Identifying Safety Subgroups at Risk: Assessing the Agreement Between Statistical Alerting and Patient Subgroup Risk

A. Bate, F. Haguinet, Olivia Mahaux, 2023, Drug Safety.

Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view.

V. Bauchau, D. Rosillon, L. Baril, 2017, Vaccine.

Influenza – the need to stay ahead of the virus

B. Flannery, I. Julkunen, N. Ikonen, 2015 .